高血压患者全麻诱导期间血清Apelin-12和AngⅡ的变化<sup>*</sup>

doi:10.3969/j.issn.1671-7171.2021.04.011

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (1137 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the changes of serum Apelin-12 and AngⅡ in hypertensive patients during induction of general anesthesia, to evaluate their vascular protection, and to provide guidance for the patient's postoperative outcome. 【Methods】 From September 2018 to November 2019, 80 patients who underwent laparoscopic gallbladder surgery in the Second Affiliated Hospital of Shanxi Medical University were selected. According to whether they had hypertension, they were divided into hypertension group and control group with 40 cases each. The changes of systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and ST-T of ECG before and after induction of general anesthesia in each group were recorded. Enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of serum Apelin-12 and angiotensin Ⅱ (Ang Ⅱ) before and after induction of general anesthesia and related analysis. 【Results】 After induction of general anesthesia, serum Apelin-12 decreased and AngⅡ increased in the hypertensive group. The difference was statistically significant (P<0.05), while there was no significant change in the control group (P>0.05). 【Conclusion】 After induction of general anesthesia in hypertensive patients, serum Apelin-12 decreases and AngⅡ increases, suggesting an increased risk of cardiovascular events. Intraoperative precautions should be strengthened to ensure surgical safety.

Key words： Hypertension Anesthesia,General Angiotensin Ⅱ/BL

Received: 05 February 2021

PACS:

R544.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WEN Miao-miao
	FAN Jun-bai

Cite this article:

WEN Miao-miao,FAN Jun-bai. Changes of Serum Apelin-12 and AngⅡ in Hypertensive Patients During Induction of General Anesthesia[J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(4): 519-521.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2021.04.011 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2021/V38/I4/519

[1] KIM S, GOEL R, KUMAR A, et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure[J].Clin Sci (London, England : 1979),2018,132(6):701-718.
[2] 刘建军. 关于高血压病人手术时麻醉处理[J].世界最新医学信息文摘, 2017,17(34):119.
[3] TATEMOTO K, HOSOYA M, HABATA Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J].Biochem Biophys Res Commun,1998,251(2):471-476.
[4] LUO X. Apelin/APJ system: A critical regulator of vascular smooth muscle cell[J].J Cell Physiol,2018,233(7):5180-5188.
[5] XIE H, LUO G, ZHENG Y, et al. Lowered circulating apelin is significantly associated with an increased risk for hypertension: A meta-analysis[J].Clin Exp Hypertens,2017,39(5):435-440.
[6] 黄扬, 闻慧娟, 贾海波, 等. 血清脂肪因子vaspin、apelin、chemerin与老年高血压病人血压变异的相关性分析[J].热带医学杂志, 2019,19(6):743-746.
[7] 阿斯艳木?阿不都欧甫, 商鲁翔, 周贤惠, 等. Apelin/APJ系统与心血管疾病的研究进展[J].中国心脏起搏与心电生理杂志, 2019,33(2):163-166.
[8] 杨鸣. 高血压患者围术期的麻醉用药及处理[J].中西医结合心血管病电子杂志, 2015,3(36):38-39.
[9] KUROWSKA P, BARBE A, ROZYCKA M, et al. Apelin in Reproductive Physiology and Pathology of Different Species: A Critical Review[J].Int J Endocrinol,2018,2018:9170480.
[10] 李莉芳, 肖建华. Apelin/APJ系统在心血管疾病中的生理与病理作用[J].中南医学科学杂志, 2019,47(5):452-457.
[11] 李赫宁, 陈临溪. Apelin/APJ系统:动脉粥样硬化治疗新靶点[J].中国动脉硬化杂志, 2019,27(7):553-561.
[12] YEGANEH-HAJAHMADI M, NAJAFIPOUR H, ROSTAMZADEH F. The differential effects of low and high doses of apelin through opioid receptors on the blood pressure of rats with renovascular hypertension[J].Hypertens Res,2017,40(8):732-737.
[13] 田艳君, 姜云璐, 韩爱忠, 等. Apelin/APJ系统及其基因多态性与心脑血管疾病的相关性[J].生理科学进展, 2019,50(6):423-428.
[14] LIAKOS C I, SANIDAS E A, PERREA D N, et al. Apelin and visfatin plasma levels in healthy individuals with high normal blood pressure[J].Am J Hyperten,2016,29(5):549-552.
[15] TOPUZ M, OZ F, AKKUS O, et al. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention[J].Perfusion,2017,32(3):206-213.
[16] YING Z, JIANSONG Y, YONG W, et al. Serum apelin predicts spontaneous reperfusion of infarct-related artery in patients with ST-segment elevation myocardial infarction[J].Coron Artery Dis,2019,30(2):103-108.